Medicine Information

Bextra and Vioxx Withdrawal Spurs Price Increase Among Rivals


The market for painkillers is huge. People don't like pain and inflammation, and last year Americans spent nearly $4 billion on just two of them - Vioxx and Bextra. Those two drugs, part of a family of non-steroidal anti-inflammatory drugs known as COX-2 inhibitors, were withdrawn from the market recently amid concerns that they can cause heart attacks and strokes. The loss of these two drugs to the marketplace is huge, as they were the two largest sellers in a fairly narrow field. COX-2 inhibitors differ from traditional non-steroidal anti-inflammatory drugs in that they inhibit production of the COX-2 enzyme that causes inflammation but do not interfere with COX-1, the enzyme that protects the stomach lining. Patients who use these drugs are thought to suffer less from internal discomfort and bleeding than those who took traditional anti-inflammatories, such as naproxen and ibuprofen.

With the withdrawal of these two blockbusters, patients with chronic pain, such as arthritis sufferers, are now going back to older painkillers, such as Mobic, Motrin, and Relafen. Since the more popular Vioxx and Bextra are no longer available, these older drugs are enjoying a resurgence in popularity, and sales are up across the board. So, it seems, are their prices. A recent study by a popular consumer publication shows that prices of some three dozen anti-inflammatory medications have gone up since Vioxx was withdrawn from the market in September 2004. The increases average about ten percent. Why have the prices of these older, established medications all gone up at once?

The answer, simply, is that the pharmaceutical companies have raised the prices because they can. The market for drugs is wildly competitive, and manufacturers are constantly seeking any advantage they can find in the marketplace. The sudden withdrawal of two of the most popular and profitable medications has provided a rare opportunity for manufacturers to increase both sales and prices at the same time, as the drug makers know that patients must switch to another medication. It's good for their stockholders, but bad for those who suffer from pain.

Will the high prices last? Probably not. Pricing of highly competitive medications tends to be volatile. The prices may stay up in the short term, but other medications may be introduced soon, or Bextra or Vioxx may be returned to the market. The introduction of other drugs will restore more competition to the market, and prices may drop once again. The market for painkilling drugs is a bit of a crazy one, and patients should simply exhibit some, well, patience.

©Copyright 2005 by Retro Marketing.

Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.


MORE RESOURCES:

Market Wire (press release)

San Diego Hospice and The Institute for Palliative Medicine ...
MarketWatch - Oct 11, 2008
World Day helps to raise awareness about the practice of palliative medicine, in an effort to bring effective medical practices that aid in preventing and ...
San Diego Hospice and The Institute for Palliative Medicine ... International Business Times
all 13 news articles


Police chief's death stuns Medicine Hat
Calgary Herald,  Canada - 1 hour ago
The death of Medicine Hat police Chief Gord Earl has left a void within the organization he served for more than 30 years. Earl died of an apparent heart ...
Medicine Hat Police Chief dies. Medicine Hat News
Medicine Hat police chief dies suddenly Calgary Herald
all 4 news articles


Protection Is the Best Medicine
Wheeling News Register, WV - 2 hours ago
And with a recent syphilis outbreak in Ohio County, health officials want people to know that prevention - as in protection - is the best medicine. ...


Where does your candidate stand on medicine's issues?
American Medical News (subscription) - 5 hours ago
And they have worked with organized medicine to help ensure patient safety by appropriately limiting nonphysician scope of practice. At the federal level, ...
Stake your claim for accurate reimbursement American Medical News (subscription)
all 2 news articles


Turn to 10.com

An industry takes its medicine
Baltimore Sun, United States - Oct 10, 2008
Just in time for cold and flu season, manufacturers of popular over-the-counter cold and cough medicines have said they will stop marketing their remedies ...
Leading Homeopathic Medicine Provider, Hyland's Inc., Offers ... MarketWatch
Editorial: FDA warns against giving over-the-counter cold medicine ... The Grand Rapids Press - MLive.com
Health Matters: Cough Medicine and Your Child WCTV
Medical News Today (press release) - Newsinferno.com
all 387 news articles


CBS News

Sometimes 'new breakthroughs' in medicine are too new
Southtown Star, IL - 22 hours ago
And I gave them over-the-counter cold medicine when they had persistent, hacking coughs and sore throats. Turns out that wasn't a good idea, either. ...
Latina teens lag in vaccinations for cervical cancer Los Angeles Times
One In Four Teenage Girls Received HPV Vaccine In Its First Full ... Medical News Today (press release)
US Vaccine Use Increased In 2007 eFluxMedia
University Daily Kansan - Seattle Times
all 517 news articles


Ex-employee, Cardinal both profited in buying discounted medicine
Columbus Dispatch, OH - 21 hours ago
It also retains its Medicine Shoppe International pharmacies and its outsourced pharmacy management services, although it is considering shedding these ...


Medicine, food will see you through in times of trouble
Economic Times, India - 10 hours ago
While bearishness has enveloped almost every asset in the current market, there are still certain sectors, which offer a ray of hope and potential to give ...


Quark Pharmaceuticals Announces Publication of Study on Use of ...
MarketWatch - 7 hours ago
Professor Shyam Biswal of the Division of Pulmonary and Critical Care Medicine, School of Medicine, Johns Hopkins University, principal investigator of the ...


Politics of Health Care Explored in New Issue of Stanford Medicine ...
MarketWatch - Oct 10, 2008
... Yorker cover illustration of Barack and Michelle Obama, created the cover for the new issue of Stanford Medicine magazine on politics and health care. ...
Reforming Health Care New York Times
all 8 news articles

Medicine - Google News

home | site map
© 2006